Back to results
US 2026/0083838 A1Published application
Adjuvant Composition Comprising STING Agonists
AssigneeGlaxosmithkline Biologicals SA
InventorsKamelia BEHNIA, Dunja SOBOT, Laurent STRODIOT
Life of this patent
Estimating the term…
Abstract
The present application relates to an adjuvant composition comprising: (i) a STING agonist of Formula (I) or a pharmaceutically acceptable salt thereof and (ii) aluminium hydroxide, aluminium phosphate, aluminium oxyhydroxide, or aluminium hydroxy phosphate; immunogenic compositions comprising the adjuvant composition, their use in methods of immunising a subject, and related aspects thereof.
Claims18
An adjuvant composition comprising:
- (i) a STING agonist of Formula (I) or a pharmaceutically acceptable salt thereof:
- Formula (I) being:
- wherein:
- X is a -halo(C1-C5)alkyl, an unsubstituted —C1-C5 alkyl, or an unsubstituted —C2-C5 alkenyl;
- R1 and R9 are independently H, a halogen, a hydroxyl, —O—P(O)(OH)2, —O—P(O)(R)2, an optionally substituted C1-C6 alkyl, or an optionally substituted C1-C6 alkyloxy,
- wherein the optionally substituted C1-C6 alkyl and the optionally substituted C1-C6 alkyloxy are independently optionally substituted with one to four substituents, each independently selected from:
- a hydroxyl, —O—P(O)(OH)2, —O—P(O)(RI)2, a C1-C4 alkoxyl, a —N(RA)2, a —CO2(RB), an optionally substituted phenyl, and an optionally substituted 5-6 membered heterocycloalkyl,
- wherein the optionally substituted phenyl and the optionally substituted 5-6 membered heterocycloalkyl are each optionally substituted by one to four substituents, each independently selected from:
- a halogen, a hydroxy, —O—P(O)(OH)2, —O—P(O)(RI)2, an amino, a (C1-C6 alkyl)amino-, a (C1-C6 alkyl)(C1-C6 alkyl)amino-, a halo(C1-C6 alkyl), a hydroxy-(C1-C4 alkyl)-, a —(C1-C4 alkyl)-O—P(O)(OH)2, a —(C1-C4alkyl)-O—P(O)(RI)2, a halo(C1-C4 alkoxy)-, a C1-C4 alkoxy-, a hydroxy-(C2-C4 alkoxy)-, a —(C2-C4 alkoxy)-O—P(O)(OH)2, a —(C2-C4 alkoxy)-O—P(O)(RI)2, a —(C1-C6 alkyl)-NH2, a —C1-C4 alkyl-(C1-C4 alkoxyl), and a C1-C4 alkoxy-(C1-C4 alkoxy)-,
- wherein RA and RB are each independently selected from:
- H, a —C1-C4 alkyl, a —CO(C1-C4 alkyl), a —OCO(C1-C4 alkyl), a —(C1-C4 alkyl)-NH2, a —(C1-C4 alkyl)-C1-C4 alkoxyl, and a —CO2(C1-C4 alkyl),
- R2 and R7 are:
- (a) each independently H, a —CON(RC)2, —COOH, or a CO2(RD), or
- (b) one of R2 and R7 is —CON(RC)(RD) and the other of R2 and R7 is H, —COOH, or CO2(RE), wherein RC and RD are each independently selected from H, a —C1-C4 alkyl, a —CO(C1-C4 alkyl), a —OCO(C1-C4 alkyl), a —(C1-C4 alkyl)-NH2, a —(C1-C4 alkyl)-C1-C4 alkoxyl, or a —CO2(C1-C4 alkyl);
- R3 and R8 are each independently H, a halo(C1-C6alkyl), a halo(C1-C6alkoxy)-, a hydroxy, —O—P(O)(OH)2, a —O—P(O)(RI)2, a —NRCRDa —CORC, a —CO2RC, a —N(RD)CORC, a —N(RD)SO2RC, a —N(Rg)SO2(C1-C2alkyl)-N(Rh)(Rf), or a —N(Rg)CO(C1-C2alkyl)-N(Rh)(Rf);
- wherein Re, Rf, Rg, and Rh are each independently H or a C1-C4 alkyl;
- R4, R5, R11, and R12 are each independently H or C1-C4 alkyl;
- R6 and R10 are each C1-C4 alkyl;
- and each occurrence of R is independently C1-C6 alkyloxy-;
- and
- (ii) an aluminium salt comprising aluminium hydroxide, aluminium phosphate, aluminium oxyhydroxide, or aluminium hydroxyphosphate.
18 more elements
Dependencies are inferred from the claim text.